Measurement of fecal elastase improves performance of newborn screening for cystic fibrosis  Juerg Barben, Corina S. Rueegg, Maja Jurca, Johannes Spalinger,

Slides:



Advertisements
Similar presentations
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
Advertisements

Cheryl Cameron, Mark W. Lodes, William M. Gershan 
C. P. B. van der Ploeg, M. E. van den Akker-van Marle, A. M. M
Cystic Fibrosis Foundation and European Cystic Fibrosis Society Survey of cystic fibrosis mental health care delivery  J. Abbott, J.S. Elborn, A.M. Georgiopoulos,
Cystic Fibrosis The Journal of Molecular Diagnostics
Long-term follow-up of cystic fibrosis newborn screening: Psychosocial functioning of adolescents and young adults  Audrey Tluczek, Anita Laxova, Adam.
Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A new designation and management recommendations for infants with an inconclusive diagnosis.
Sweat conductivity: An accurate diagnostic test for cystic fibrosis?
Towards an individualized protocol for workload increments in cardiopulmonary exercise testing in children and adolescents with cystic fibrosis  H.J.
Newborn screening for cystic fibrosis — The parent perspective
R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J
Abaigeal D. Jackson, Christopher H. Goss  Journal of Cystic Fibrosis 
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
Spectrum of mutations in CFTR in Finland: 18 years follow-up study and identification of two novel mutations  Satu Kinnunen, Sandra Bonache, Teresa Casals,
Measuring and improving respiratory outcomes in cystic fibrosis lung disease: Opportunities and challenges to therapy  Edith T. Zemanick, J. Kirk Harris,
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Samantha A. Woodruff, Marci K. Sontag, Frank J. Accurso, Ronald J
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Nadav Traeger, Qiuhu Shi, Allen J. Dozor  Journal of Cystic Fibrosis 
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Laura Viviani, Baroukh M. Assael, Eitan Kerem 
A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study  Maret L. Maliniak, Arlene A.
Cirrhosis and other liver disease in cystic fibrosis
Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin 
Rate of improvement of CF life expectancy exceeds that of general population— Observational death registration study  Matthew N. Hurley, Tricia M. McKeever,
Controlled clinical trials in cystic fibrosis — are we doing better?
Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Disposition index identifies defective beta-cell function in cystic fibrosis subjects with normal glucose tolerance  L. Merjaneh, Q. He, Q. Long, L.S.
Prenatal diagnosis for CF using High Resolution Melting Analysis and simultaneous haplotype analysis through QF-PCR  Myrto Poulou, Aspasia Destouni, Georgia.
A.H. Gifford  Journal of Cystic Fibrosis 
Inhalation solutions — Which ones may be mixed
Antonia V. Bennett, Donald L. Patrick, James F. Lymp, Todd C
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Cystic fibrosis transmembrane conductance regulator gene variants are associated with autoimmune pancreatitis and slow response to steroid treatment 
The expansion and performance of national newborn screening programmes for cystic fibrosis in Europe  Jürg Barben, Carlo Castellani, Jeannette Dankert-Roelse,
Sally H. Pattison, Geraint B. Rogers, Martin Crockard, J
Nasal polyposis in lung transplant recipients with cystic fibrosis
Chee Y. Ooi, Peter R. Durie  Journal of Cystic Fibrosis 
Erratum The American Journal of Human Genetics
D.Y.F. Mak, J. Sykes, A.L. Stephenson, L.C. Lands 
Danieli Barino Salinas, Patrick R
Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United.
Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic  Amanda L. Griffiths, Danielle F. Wurzel,
Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention  H. White, K. Pollard, C. Etherington, I. Clifton,
Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire  Joän M. Patterson, Melanie Wall, Jerica.
Segregation of children with CF diagnosed via newborn screening and acquisition of Pseudomonas aeruginosa  Karen O. McKay, Peter J. Cooper, Peter P. van.
Higher risk of hospitalization among females with cystic fibrosis
F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal 
V. Thompson, N. Mayer-Hamblett, M. Kloster, D. Bilton, P.A. Flume 
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
Daniel J. Smith, Gregory J. Anderson, Scott C. Bell, David W. Reid 
Michael W. Konstan, David J. Pasta, Jeffrey S. Wagener, Donald R
C. R. Hansen, T. Pressler, K. G. Nielsen, P. Ø. Jensen, T
Retrospective analysis of stored dried blood spots from children with cystic fibrosis and matched controls to assess the performance of a proposed newborn.
CFTR modulators and pregnancy: Our work has only just begun
‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis
L. Nshimyumukiza, A. Bois, P. Daigneault, L. Lands, A. -M. Laberge, D
Beta-lactam allergy in adults with cystic fibrosis
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Treatment intensity and characteristics of MRSA infection in CF
A survey of newborn screening for cystic fibrosis in Europe
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Improved early diagnosis of Pseudomonas aeruginosa by real-time PCR to prevent chronic colonisation in a paediatric cystic fibrosis population  Elaine.
Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience  C.R.
Respiratory physicians and clinic coordinators' attitudes to population-based cystic fibrosis carrier screening  Fiona Cunningham, Sharon Lewis, Lisette.
Presentation transcript:

Measurement of fecal elastase improves performance of newborn screening for cystic fibrosis  Juerg Barben, Corina S. Rueegg, Maja Jurca, Johannes Spalinger, Claudia E. Kuehni  Journal of Cystic Fibrosis  Volume 15, Issue 3, Pages 313-317 (May 2016) DOI: 10.1016/j.jcf.2015.12.024 Copyright © 2016 European Cystic Fibrosis Society. Terms and Conditions

Fig. 1 Diagnostic procedures in the CF centers in Switzerland in place since January 2013 (protocol C). Abbreviations: CFTR, cystic fibrosis transmembrane conductance regulator; CFSPID, CF screen positive inconclusive diagnosis; Cl, chloride; GP, general practitioner; IRT, immunoreactive trypsinogen; NBS, newborn screening. Journal of Cystic Fibrosis 2016 15, 313-317DOI: (10.1016/j.jcf.2015.12.024) Copyright © 2016 European Cystic Fibrosis Society. Terms and Conditions

Fig. 2 Proportion of CFSPID among all positive diagnoses (CF+CFSPID) and families with >2months waiting time until definite diagnosis, by type of protocol. The figure shows the proportion and 95% confidence interval of CFSPID among all positive diagnoses (CF+CFSPID) and of families with more than 2months waiting time until definite (genetically confirmed) diagnosis, stratified by screening protocol. Abbreviations: CFSPID, CF screen positive inconclusive diagnosis; CI, confidence interval. Journal of Cystic Fibrosis 2016 15, 313-317DOI: (10.1016/j.jcf.2015.12.024) Copyright © 2016 European Cystic Fibrosis Society. Terms and Conditions